GSK-958108

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameGSK-958108
Drug Alias NameGSK-958108
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor antagonists
TargetsSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsPremature Ejaculation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsPremature Ejaculation

Other Information

ATC CodeN/A
Related LinksN/A